Facilities

Phase 1 Capability

  • Acute Myeloid Leukaemia
  • FLT-3 inhibition/Clofarabine combinations/Gemtuzumab combinations

First-in-Man studies

To be started 2008

Centre specific translational research interest

  • Mutation and gene array analysis
  • New agent sensitivity screening
  • Biomarkers

Multi-centre Phase 1 studies

Yes

 

Other Facilities (e.g. Wellcome Trust CRF)

  • Wales CTU
  • Clinical Research Facility
 

Sample collection

Tissue Banking Activity
Wales Cancer Bank: AML Cell Bank

Centre contact responsible for sample collection
Cancer Bank (A Parry-Jones), AML (Dr Paul White).